Author:
Yoshimi Akihide,Abdel-Wahab Omar
Publisher
Springer Science and Business Media LLC
Reference81 articles.
1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–405.
2. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW. WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. New York: WHO Press; 2008.
3. Germing U, Gattermann N, Aivado M, Hildebrandt B, Aul C. Two types of acquired idiopathic sideroblastic anaemia (AISA): a time-tested distinction. Br J Haematol. 2000;108(4):724–8.
4. Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D, et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med. 2011;365(15):1384–95.
5. Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature. 2011;478(7367):64–9.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Uveal melanoma modeling in mice and zebrafish;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-01
2. Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities;Frontiers in Oncology;2023-06-05
3. Myelodysplastic syndromes with ring sideroblasts;Hematological Oncology;2023-02-26
4. SF3B1 Mutations in Hematological Malignancies;Cancers;2022-10-08
5. RNA Therapeutics for Cancers;RNA Therapeutics - History, Design, Manufacturing, and Applications [Working Title];2022-09-16